Literature DB >> 17360627

Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.

Daniel W Young1, Mohammad Q Hassan, Xiao-Qing Yang, Mario Galindo, Amjad Javed, Sayyed K Zaidi, Paul Furcinitti, David Lapointe, Martin Montecino, Jane B Lian, Janet L Stein, Andre J van Wijnen, Gary S Stein.   

Abstract

During cell division, cessation of transcription is coupled with mitotic chromosome condensation. A fundamental biological question is how gene expression patterns are retained during mitosis to ensure the phenotype of progeny cells. We suggest that cell fate-determining transcription factors provide an epigenetic mechanism for the retention of gene expression patterns during cell division. Runx proteins are lineage-specific transcription factors that are essential for hematopoietic, neuronal, gastrointestinal, and osteogenic cell fates. Here we show that Runx2 protein is stable during cell division and remains associated with chromosomes during mitosis through sequence-specific DNA binding. Using siRNA-mediated silencing, mitotic cell synchronization, and expression profiling, we identify Runx2-regulated genes that are modulated postmitotically. Novel target genes involved in cell growth and differentiation were validated by chromatin immunoprecipitation. Importantly, we find that during mitosis, when transcription is shut down, Runx2 selectively occupies target gene promoters, and Runx2 deficiency alters mitotic histone modifications. We conclude that Runx proteins have an active role in retaining phenotype during cell division to support lineage-specific control of gene expression in progeny cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360627      PMCID: PMC1805558          DOI: 10.1073/pnas.0611419104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes.

Authors:  Diana Vradii; Stefan Wagner; Diem N Doan; Jeffrey A Nickerson; Martin Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2006-01       Impact factor: 6.384

2.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2.

Authors:  E Zelzer; D J Glotzer; C Hartmann; D Thomas; N Fukai; S Soker; B R Olsen
Journal:  Mech Dev       Date:  2001-08       Impact factor: 1.882

4.  Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.

Authors:  K Blyth; A Terry; N Mackay; F Vaillant; M Bell; E R Cameron; J C Neil; M Stewart
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

5.  A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.

Authors:  Y W Zhang; N Yasui; K Ito; G Huang; M Fujii; J Hanai; H Nogami; T Ochi; K Miyazono; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

Review 7.  Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.

Authors:  Jane B Lian; Amjad Javed; S Kaleem Zaidi; Christopher Lengner; Martin Montecino; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2004       Impact factor: 1.807

8.  Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function.

Authors:  Kristen D Brubaker; Robert L Vessella; Lisha G Brown; Eva Corey
Journal:  Prostate       Date:  2003-06-15       Impact factor: 4.104

9.  Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.

Authors:  Jose Sierra; Alejandro Villagra; Roberto Paredes; Fernando Cruzat; Soraya Gutierrez; Amjad Javed; Gloria Arriagada; Juan Olate; Maria Imschenetzky; Andre J Van Wijnen; Jane B Lian; Gary S Stein; Janet L Stein; Martin Montecino
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 10.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more
  90 in total

Review 1.  Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory information.

Authors:  Sayyed K Zaidi; Daniel W Young; Martin Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Mol Cell Biol       Date:  2010-08-09       Impact factor: 4.272

2.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.

Authors:  Rachit Bakshi; Mohammad Q Hassan; Jitesh Pratap; Jane B Lian; Martin A Montecino; Andre J van Wijnen; Janet L Stein; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Mitotic Inheritance of mRNA Facilitates Translational Activation of the Osteogenic-Lineage Commitment Factor Runx2 in Progeny of Osteoblastic Cells.

Authors:  Nelson Varela; Alejandra Aranguiz; Carlos Lizama; Hugo Sepulveda; Marcelo Antonelli; Roman Thaler; Ricardo D Moreno; Martin Montecino; Gary S Stein; Andre J van Wijnen; Mario Galindo
Journal:  J Cell Physiol       Date:  2015-09-18       Impact factor: 6.384

Review 4.  An architectural genetic and epigenetic perspective.

Authors:  Gary S Stein; Janet L Stein; Andre J van Wijnen; Jane B Lian; Sayyed K Zaidi; Jeffrey A Nickerson; Martin A Montecino; Daniel W Young
Journal:  Integr Biol (Camb)       Date:  2010-12-24       Impact factor: 2.192

5.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

6.  Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.

Authors:  Ya-Huei Kuo; Sayyed K Zaidi; Svetlana Gornostaeva; Toshihisa Komori; Gary S Stein; Lucio H Castilla
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

Review 7.  Transcription-factor-mediated epigenetic control of cell fate and lineage commitment.

Authors:  Gary S Stein; Sayyed K Zaidi; Janet L Stein; Jane B Lian; Andre J van Wijnen; Martin Montecino; Daniel W Young; Amjad Javed; Jitesh Pratap; Je-Yong Choi; Syed A Ali; Sandhya Pande; Mohammad Q Hassan
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 8.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09

9.  Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1.

Authors:  Stephan Kadauke; Maheshi I Udugama; Jan M Pawlicki; Jordan C Achtman; Deepti P Jain; Yong Cheng; Ross C Hardison; Gerd A Blobel
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 10.  Targeting deregulated epigenetic control in cancer.

Authors:  Sayyed K Zaidi; Andre J Van Wijnen; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2013-11       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.